Tyra Biosciences, Inc.
TYRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $62 | $98 | $101 | $92 |
| Short-Term Investments | $213 | $198 | $218 | $249 |
| Receivables | $2 | $2 | $2 | $2 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $4 | $4 | $4 |
| Total Curr. Assets | $281 | $302 | $325 | $347 |
| Property Plant & Equip (Net) | $7 | $7 | $7 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $13 | $12 | $11 | $8 |
| Total NC Assets | $21 | $19 | $19 | $16 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $302 | $321 | $343 | $364 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $3 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $13 | $11 | $11 | $14 |
| Total Curr. Liab. | $16 | $14 | $14 | $15 |
| LT Debt | $5 | $6 | $6 | $6 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $5 | $6 | $6 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $6 | $6 | $6 |
| Total Liabilities | $21 | $19 | $20 | $20 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$337 | -$308 | -$279 | -$251 |
| AOCI | $0 | $0 | $1 | $1 |
| Other Equity | $617 | $609 | $602 | $594 |
| Total Equity | $281 | $302 | $324 | $343 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $302 | $321 | $343 | $364 |
| Net Debt | -$56 | -$92 | -$95 | -$86 |